Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 451 results for "fda centre for drug evaluation and re..."

Homeopathic Teething Tablets, Gels Harmful For Kids: US Drug Regulator
NDTV

FDA Warns Against The Use Of Homeopathic Teething Tablets And ...

Parents who have been giving their little ones homeopathic remedies to help them deal with the pain of teething should consider stopping immediately. There's no reason for homeopathic teething tablets and gels to be in your child's life, advises ... Equilibrio Informativo, 2 months ago
Alert on homeo baby pills Calcutta Telegraph, 2 months ago

8 images for fda centre for drug evaluation and research

CNN, 2 weeks ago
Nutritional Outlook, 2 months ago
MassDevice, 2 months ago
FOXNews.com, 3 months ago
diaTribe, 3 months ago
MassDevice, 4 months ago
Drug Store News, 4 months ago
OncLive, 8 months ago

Cosmetic surgery to get affordable as VNIT develops implants

If the Food and Drug Administration (FDA) gives its approval, four different types of implants will soon be manufactured in the city. A group of researchers from the mechanical engineering department at the Visvesvaraya National Institute of ...
 Times of India1 month ago
Freshnews.com

Jubilant DraxImage Receives FDA Approval for RUBY-FILL Rubidium 82 Generator and Elution System

Jubilant DraxImage's RUBY-FILL is an approved technology for PET myocardial perfusion imaging under rest & pharmacological stress conditions to evaluate regional myocardial perfusion in adult patients Jubilant DraxImage Inc., (DraxImage) ...
 Minyanville2 months ago JUBILANT LIFE SCIENCES : receives USFDA approval for RUBY-FILL®- Rubidium 82 Generator and Elution System  4 Traders2 months ago
[x]  

New nanomedicine approach aims to improve HIV drug therapies

Home » Health » / no comments New research led by the University of Liverpool aims to improve the administration and availability of drug therapies to HIV patients through the use of nanotechnology. The research, conducted by the ...
 HealthMediciNet.com1 month ago

FDA Approves Continued Access to ReCell in US Burns Trial

By a News Reporter-Staff News Editor at Biotech Week The US Food and Drug Administration has approved Continued Access to ReCell, allowing US burns surgeons participating in Avita Medical's regulatory trial to treat new patients using the Company's ...
 Pharmacy Choice1 month ago 10/19/16 - FDA Approves Continued Access to ReCell in US Burns Trial  Pharmacy Choice1 month ago AVITA MEDICAL : FDA Approves Continued Access to ReCell in US Burns Trial  4 Traders1 month ago

Tetra Bio granted pre-IND FDA meeting for cannabis drug

TETRA BIO-PHARMA INC. ANNOUNCES ITS PRE-IND MEETING WITH FDA WAS GRANTED Tetra Bio Pharma Inc., through its subsidiary, PhytoPain Pharma Inc. (PPP), has received a pre-IND acknowledgement and meeting request granted letter from the U.S. Food and ...
 Stockwatch2 months ago

Cubresa SPECT Scanner Used for Evaluation of Alzheimer's Disease Molecular Label in vivo November 22, 2016Cubresa's SPECT scanner was used in a study by Dalhousie University and Mount Saint Vincent University to determine if a...

Wild-Type and 5XFAD Alzheimer's disease (AD) model brains revealing elevation of BChE in AD. SPECT imaging has provided us the first direct in vivo evidence that the TRV6001 label can cross the blood-brain barrier -- lead author Drew DeBay ...
 PRWeb2 weeks ago

CRS IC organises day-long seminar on 'clinical approach for drug delivery systems'

A day-long national seminar on Clinical Approaches to the Novel Drug Delivery systems and the Global Regulatory Requirements, was conducted by Controlled Release Society Indian Chapter (CRS IC). Held on October 15th, 2016, the aim of this seminar ...
 PharmaBiz1 month ago
PharmaVOICE

Helix Biopharma Accelerates Escalation Of L-DOS47 Dosing In The U.S. Phase I Study

) - Helix BioPharma Corp. (TSX: HBP ) (FRANKFURT: HBP), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, is pleased to announce that after reviewing safety data from the Phase ...
 BioSpace1 week ago Helix BioPharma Corp. Accelerates Escalation of L-DOS47 Dosing in the U.S. Phase I Study  Yahoo! Canada1 week ago Helix BioPharma Corp. : Accelerates Escalation of L-DOS47 Dosing in the U.S. Phase I Study  4 Traders1 week ago
[x]  

Exelixis Announces Presentation of Cobimetinib Combination Therapy Data at the Society for Melanoma Research 2016 Congress That Support Genentech's Planned Phase 3 Pivotal Trials

- Encouraging data in BRAF wild type advanced melanoma presented in advance of initiation of phase 3 pivotal trial next year - - The third pivotal phase 3 trial of cobimetinib announced this year, reflecting robust late-stage development program ...
 Enhanced Online News1 month ago EXELIXIS : Announces Presentation of Cobimetinib Combination Therapy Data at the Society for Melanoma Research 2016 Congress That Support Genentech's Planned Phase 3 Pivotal Trials  4 Traders1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less